Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma

BACKGROUND: The beneficial effect of postoperative radiotherapy (PORT) on completely resected pathological IIIA-N2 (pIIIA-N2) non-small cell lung cancer (NSCLC) has been a subject of interest with controversy. The aim of the study was to distinguish the clinical efficacy of PORT on lung adenocarcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Cuimeng, Liu, Guimei, Xu, Yongxiang, Xia, Guangrong, Zhang, Tongmei, Huang, Jiaqiang, Jiang, Hui, Ming Wang, Ji, Li, Baolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877270/
https://www.ncbi.nlm.nih.gov/pubmed/33885242
http://dx.doi.org/10.2478/raon-2020-0070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877270/
https://www.ncbi.nlm.nih.gov/pubmed/33885242
http://dx.doi.org/10.2478/raon-2020-0070

Ejemplares similares